Carod-ArtalFJ. Neurological complications of coronavirus and COVID-19. Rev Neurol2020; 70: 311–322.
2.
Dominguez-GilBCollEFerrer-FabregaJ, et al. Dramatic impact of the COVID-19 outbreak on donation and transplantation activities in Spain. Cir Esp. Epub ahead of print 17April2020. DOI: 10.1016/j.ciresp.2020.04.012.
3.
MitjaOArenasARodoX, et al. Experts’ request to the Spanish government: move Spain towards complete lockdown. Lancet2020; 395: 1193–1194.
4.
Legido-QuigleyHMateos-GarciaJTCamposVR, et al. The resilience of the Spanish health system against the COVID-19 pandemic. Lancet Public Health2020; 5: e251–e252.
5.
WaldmanGMayeuxRClaassenJ, et al. Preparing a neurology department for SARS-CoV-2 (COVID-19): Early experiences at Columbia university Irving medical center and the New York Presbyterian hospital in New York City. Neurology2020; 94: 886–891.
6.
KleinBCBusisNA. COVID-19 is catalyzing the adoption of teleneurology. Neurology. Epub ahead of print 1April2020. DOI: 10.1212/WNL.0000000000009494.
7.
EscalonMXHerreraJ. Adapting to the COVID-19 pandemic in New York City. Am J Phys Med Rehabil. Epub ahead of print 21April2020. DOI: 10.1097/PHM.0000000000001451.
8.
Costa-FrossardLMoreno-TorresIMeca-LallanaV, et al. [EMCAM (Multiple sclerosis autonomous community of Madrid) document for the management of patients with multiple sclerosis during the SARS-CoV-2 pandemic]. Rev Neurol2020; 70: 329–340.
9.
BrownleeWBourdetteDBroadleyS, et al. Treating multiple sclerosis and neuromyelitis optica spectrum disorder during the COVID-19 pandemic. Neurology2020; 10: 1212.
10.
Sormani MP and Italian Study Group on COVID-19 infection in multiple sclerosis. An Italian programme for COVID-19 infection in multiple sclerosis. Lancet Neurol2020. Epub ahead of print 30April2020. DOI: 10.1016/S1474-4422(20)30147-2.